ArticleJournal of multidisciplinary healthcare2025
Neonatal Hearing Loss Risk Factors and miRNA Biomarkers Identified Through AABR Screening.
Article in Journal of multidisciplinary healthcare, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The differential expression profiles of miRNA in serum-derived exosomes and its potential role in age-related hearing loss.Frontiers in aging neuroscience · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To determine the prevalence of hearing impairment in neonates and identify associated risk factors through auditory brainstem response (ABR) screening. Study Design: A prospective observational longitudinal study was conducted involving 158 infants, with Automated Auditory Brainstem Response (AABR) evaluations performed by 6 months of age. Setting: The study was undertaken in a hospital-based neonatal care unit. Methods: Infants with significant hearing loss in one or both ears were referred for further assessment and rehabilitation. The relationship between microRNAs (MiRNAs) and congenital hearing loss was confirmed through differential expression levels in newborns. Results: Of the 158 infants, 8 showed abnormal AABR results. Univariable analysis identified 5 potential risk factors associated with hearing deterioration, with multivariable analysis pinpointing the number of maternal embryos, cytomegalovirus, and miR-431 as independently associated with hearing loss at 6 months ( Conclusion: Early detection of hearing loss is vital for child development. Given the high incidence of hearing impairment in the study population, universal newborn hearing screening is essential. Assessment of miRNAs expression levels, maternal embryo count, and prenatal infections should be integrated into screening protocols for infants admitted for over 24 hours to prevent oversight of neural hearing loss cases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.